Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Michael Lauzardo & Charles A. Peloquin. (2016) Tuberculosis therapy for 2016 and beyond. Expert Opinion on Pharmacotherapy 17:14, pages 1859-1872.
Read now
Read now
Articles from other publishers (17)
Dagmara Ziembicka, Katarzyna Gobis, Małgorzata Szczesio, Andrzej Olczak, Ewa Augustynowicz-Kopeć, Agnieszka Głogowska, Izabela Korona-Głowniak & Krzysztof Bojanowski. (2023) Synthesis and Structure–Activity Relationship of 2,6-Disubstituted Thiosemicarbazone Derivatives of Pyridine as Potential Antituberculosis Agents. Materials 16:1, pages 448.
Crossref
Crossref
Ashlan J. Kunz Coyne, Anthony M. Casapao & Eric F. Egelund. 2023. Tuberculosis. Tuberculosis
257
275
.
Saeed Khoshnood, Elahe Taki, Nourkhoda Sadeghifard, Vahab Hassan Kaviar, Mohammad Hossein Haddadi, Zahra Farshadzadeh, Ebrahim Kouhsari, Mehdi Goudarzi & Mohsen Heidary. (2021) Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis. Frontiers in Microbiology 12.
Crossref
Crossref
Priyanka Bose, Amit K. Harit, Ratnesh Das, Samaresh Sau, Arun K. Iyer & Sushil K. Kashaw. (2021) Tuberculosis: current scenario, drug targets, and future prospects. Medicinal Chemistry Research 30:4, pages 807-833.
Crossref
Crossref
Bashir A. Sheikh, Basharat A. Bhat, Umar Mehraj, Wajahat Mir, Suhail Hamadani & Manzoor A. Mir. (2021) Development of New Therapeutics to Meet the Current Challenge of Drug Resistant Tuberculosis. Current Pharmaceutical Biotechnology 22:4, pages 480-500.
Crossref
Crossref
Edinilton Muniz Carvalho, Tercio de Freitas Paulo, Alix Sournia Saquet, Bruno Lopes Abbadi, Fernanda Souza Macchi, Cristiano Valim Bizarro, Rafael de Morais Campos, Talles Luann Abrantes Ferreira, Nilberto Robson Falcão do Nascimento, Luiz Gonzaga França Lopes, Remi Chauvin, Eduardo Henrique Silva Sousa & Vania Bernardes-Génisson. (2020) Pentacyanoferrate(II) complex of pyridine-4- and pyrazine-2-hydroxamic acid as source of HNO: investigation of anti-tubercular and vasodilation activities. JBIC Journal of Biological Inorganic Chemistry 25:6, pages 887-901.
Crossref
Crossref
Rajkumar Reddyrajula & Udaya Kumar Dalimba. (2019)
Structural modification of zolpidem led to potent antimicrobial activity in imidazo[1,2-
a
]pyridine/pyrimidine-1,2,3-triazoles
. New Journal of Chemistry 43:41, pages 16281-16299.
Crossref
Crossref
Daniel L. Clemens, Bai-Yu Lee, Aleidy Silva, Barbara Jane Dillon, Saša Masleša-Galić, Susana Nava, Xianting Ding, Chih-Ming Ho & Marcus A. Horwitz. (2019) Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs. PLOS ONE 14:5, pages e0215607.
Crossref
Crossref
Rajkumar Reddyrajula, Udayakumar Dalimba & S. Madan Kumar. (2019) Molecular hybridization approach for phenothiazine incorporated 1,2,3-triazole hybrids as promising antimicrobial agents: Design, synthesis, molecular docking and in silico ADME studies. European Journal of Medicinal Chemistry 168, pages 263-282.
Crossref
Crossref
А. G. NАUMOV & А. V. PАVLUNIN. (2018) PERSPECTIVES OF TARGETED CHEMOTHERAPY WITH DELAMANID IN THE TREATMENT REGIMENS OF THOSE WITH MULTIPLE/EXTENSIVE DRUG RESISTANT TUBERCULOSIS. A SUCCESS, CHANCE OR UNCERTAINTY?. TUBERCULOSIS AND LUNG DISEASES 96:11, pages 74-82.
Crossref
Crossref
Julie Laborde, Céline Deraeve & Vania Bernardes-Génisson. (2017) Update of Antitubercular Prodrugs from a Molecular Perspective: Mechanisms of Action, Bioactivation Pathways, and Associated Resistance. ChemMedChem 12:20, pages 1657-1676.
Crossref
Crossref
Priyanka Bose, Amit K Harit & Kamal Krishna Halder. (2017) Tuberculosis: Still a Way to go ahead for a Lead- A Review. Journal of Analytical & Pharmaceutical Research 5:6.
Crossref
Crossref
Michele Spinicci, Lorenzo Zammarchi & Alessandro Bartoloni. (2017) Tuberculosis in the Mediterranean Region. Current Tropical Medicine Reports 4:2, pages 89-94.
Crossref
Crossref
Muzafar Ahmad Rather, Ali Mohd Lone, Bisma TeliZubair Shanib Bhat, Paramjeet Singh, Mubashir Maqbool, Bashir Ahmad Shairgojray, Mohd Jamal Dar, Shajrul Amin, Syed Khalid YousufBilal A. BhatZahoor Ahmad. (2017) The synthesis, biological evaluation and structure–activity relationship of 2-phenylaminomethylene-cyclohexane-1,3-diones as specific anti-tuberculosis agents. MedChemComm 8:11, pages 2133-2141.
Crossref
Crossref
M.J. Pucci, C. Callebaut, A. Cathcart & K. Bush. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
511
552
.
Gina Gualano, Susanna Capone, Alberto Matteelli & Fabrizio Palmieri. (2016) New Antituberculosis Drugs: From Clinical Trial to Programmatic Use. Infectious Disease Reports 8:2, pages 6569.
Crossref
Crossref
Laura Iannazzo, Daria Soroka, Sébastien Triboulet, Matthieu Fonvielle, Fabrice Compain, Vincent Dubée, Jean-Luc Mainardi, Jean-Emmanuel Hugonnet, Emmanuelle Braud, Michel Arthur & Mélanie Etheve-Quelquejeu. (2016)
Routes of Synthesis of Carbapenems for Optimizing Both the Inactivation of
l
,
d
-Transpeptidase Ldt
Mt1
of
Mycobacterium tuberculosis
and the Stability toward Hydrolysis by β-Lactamase BlaC
. Journal of Medicinal Chemistry 59:7, pages 3427-3438.
Crossref
Crossref